LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 59c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q3 EPS of ($0.59). Revenue for the quarter came in at $12.5 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Allegiant adds nine new nonstop routes to Florida for spring 2027
• Progressive Corp. (PGR) call put ratio 1 call to 6.5 puts with a focus on August 202.50 puts